SIRT1 and central nervous system cancer: Silencing SIRT1 increases epithelial markers and decreases mesenchymal markers, suggesting that SIRT1 promotes EMT (epithelial–mesenchymal transition) in glioma cells, facilitating their invasive capabilities [51].